Point72 Europe (London) LLP Oric Pharmaceuticals, Inc. Transaction History
Point72 Europe (London) LLP
- $1.97 Billion
- Q3 2025
A detailed history of Point72 Europe (London) LLP transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Point72 Europe (London) LLP holds 113 shares of ORIC stock, worth $1,479. This represents 0.0% of its overall portfolio holdings.
Number of Shares
113Holding current value
$1,479% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ORIC
# of Institutions
157Shares Held
105MCall Options Held
35.1KPut Options Held
173K-
Nextech Invest, Ltd. Zurich, V87.16MShares$93.8 Million13.08% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$88.1 Million6.03% of portfolio
-
Vr Adviser, LLC New York, NY6.6MShares$86.4 Million11.96% of portfolio
-
Viking Global Investors LP6.57MShares$86 Million0.22% of portfolio
-
Nextech Invest Ag5.29MShares$69.2 Million7.95% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $518M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...